Chi's Enterprise Inc
Letter data
- Company
- Chi's Enterprise Inc
- Recipient
- Ms. Weijia D. Chi | President and Owner | Chi's Enterprise Inc | 1435 North Brasher St. | Anaheim | , | CA | 92807 | United States
- Issue date
- 2020-04-08
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations West Division 5
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 542724
- Reference number
- 542724-18
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Chi's Enterprise Inc
MARCS-CMS 542724 —
April 08, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Reference #:
542724-18
Product:
Dietary Supplements
Recipient:
Recipient Name
Ms. Weijia D. Chi
Recipient Title
President and Owner
Chi's Enterprise Inc
1435 North Brasher St.
Anaheim
,
CA
92807
United States
Issuing Office:
Office of Human and Animal Food Operations West Division 5
United States
Dear Ms. Chi:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #542724-18 dated April 30, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Sergio Chavez, Compliance Branch Director
Office of Human and Animal Food Operations
West Division 5
Content current as of:
04/24/2020
Regulated Product(s)
Dietary Supplements